Fenticonazole Nitrate for Treatment of Vulvovaginitis: Efficacy, Safety, and Tolerability of 1-Gram Ovules, Administered as Ultra-Short 2-Day Regimen

REFERENCES

• Sobel JD. Vaginitis. N Engl J Med 1997; 337: 1896–1903.
   PubMed Web of Science ®Google Scholar
• Hay PE. Therapy of bacterial vaginosis. J Antimicrob Chemother 1998; 41 (1): 6–9.
   PubMed Web of Science ®Google Scholar
• Haefner HK. Current evaluation and management of vulvovaginitis. Clin Obstet Gynecol 1999; 42 (2): 184–195.
   PubMed Web of Science ®Google Scholar
• Pray WS. Treatment of vaginal fungal infections. U S Pharmacist 2001; 26 (9): 1–5.
   Google Scholar
• Carr PL, Felsenstein D, Friedman RH. Evaluation and management of vaginitis. J Gen Intern Med 1998; 13 (5): 335–346.
   PubMed Web of Science ®Google Scholar
• Schaaf VM, Perez-Stable EJ, Borchardt K. The limited value of symptoms and signs in the diagnosis of vaginal infec-tions. Arch Intern Med 1990; 150 (9): 1929–1933.
   PubMed Web of Science ®Google Scholar
• Egan ME, Lipsky MS. Diagnosis of vaginitis. Am Fam Physician 2000; 62 (5): 1095–1104.
   PubMed Web of Science ®Google Scholar
• Bornstein J, Lakovsky Y, Lavi I, Bar-Am A, Abramovici H. The classic approach to diagnosis of vulvovaginitis: a criti-cal analysis. Infect Dis Obstet Gynecol 2001; 9 (2): 105–111.
   PubMedGoogle Scholar
• Hill GB. The microbiology of bacterial vaginosis. Am J Obstet Gynecol 1993; 169(2 Pt 2): 450-454.
   Google Scholar
• Gonzalez Pedraza AA, Ortiz Zaragoza MC, Irigoyen CA. Bacterial vaginosis a “broad overview”. Rev Latinoam Microbiol 1999; 41 (1): 25–34.
   PubMedGoogle Scholar
• Petrin D, Delgaty K, Bhatt R, Garber G. Clinical and microbiological aspects of Trichomonas vaginalis. Clin Microbiol Rev 1998; 11 (2): 300–317.
   PubMed Web of Science ®Google Scholar
• Geiger AM, Foxman B. Risk factors for vulvovaginal candidiasis: a case-control study among university students. Epidemiology 1996; 7 (2): 182–187.
   PubMed Web of Science ®Google Scholar
• Hurley R, De Louvois J. Candida vaginitis. Postgrad Med J 1979; 55 (647): 645–647.
   PubMed Web of Science ®Google Scholar
• Sweet RL. Importance of differential diagnosis in acute vaginitis. Am J Obstet Gynecol 1985; 152 (7 Pt 2): 921-923.
   Google Scholar
• Ferris DG, Litaker MS, Woodward L, Mathis D, Hendrich J. Treatment of bacterial vaginosis: a comparison of oral metronidazole, metronidazole vaginal gel, and clindamycin vaginal cream. J Fam Pract 1995; 41 (5): 443–449.
   PubMed Web of Science ®Google Scholar
• Periti P, Cohen J, Giannotti B, Periti E, Orlandini L. Fenticonazole as antimicrobial chemotherapy of superficial fungal infections. J Chemother 1999; 11 Supp. 3: 3-42.
   Google Scholar
• Sobel JD. Treatment of vaginal Candida infections. Expert Opin Pharmacother 2002; 3 (8): 1059–1065.
   PubMedGoogle Scholar
• Redondo-Lopez V, Meriwether C, Schmitt C, Opitz M, Cook R, Sobel JD. Vulvovaginal candidiasis complicating recurrent bacterial vaginosis. Sex Transm Dis 1990; 17 (1): 51–53.
   PubMed Web of Science ®Google Scholar
• Taylor CA, Lipsky MS. Physicians' perceptions of the impact of the reclassification of vaginal antifungal agents. J Fam Pract 1994; 38 (2): 157–160.
   PubMed Web of Science ®Google Scholar
• Ferris DG, Nyirjesy P, Sobel JD, Soper D, Pavletic A, Litaker MS. Over-the-counter antifungal drug misuse associat-ed with patient-diagnosed vulvovaginal candidiasis. Obstet Gynecol 2002; 99 (3): 419–425.
   PubMed Web of Science ®Google Scholar
• Nardi D, Cappelletti R, Catto A, Leonardi A, Tajana A, Veronese M. New alpha-aryl-beta,N-imidzolylethyl benzyl and naphthylmethyl ethers with antimycotic and antibacterial activ-ity. Arzneimittelforschung 1981; 31 (12): 2123–2126.
   PubMed Web of Science ®Google Scholar
• Veronese M, Salvaterra M, Barzaghi D. Fenticonazole, a new imidazole derivative with antibacterial and antifungal activity. In vitro study. Arzneimittelforschung 1981; 31 (12): 2133–2137.
   PubMed Web of Science ®Google Scholar
• Jones BM, Geary I, Lee ME, Duerden BI. Comparison of the in vitro activities of fenticonazole, other imidazoles, metronidazole, and tetracycline against organisms associated with bacterial vaginosis and skin infections. Antimicrob Agents Chemother 1989; 33 (6): 970–972.
   PubMed Web of Science ®Google Scholar
• Fontana C, Cammarata E, Greco M, Oliveri S. In vitro activity of fenticonazole on Trichomonas vaginalis and Gardenerella vaginalis. Curr Ther Res 1990; 48: 44–51.
   Web of Science ®Google Scholar
• Schneider D, Caspi E, Arieli S, Bukovski I. Fenticonazole in the treatment of vaginal candidiasis. Adv Ther 1990; 7: 355–361.
   Google Scholar
• Gastaldi A. Treatment of vaginal candidiasis with fenti-conazole and miconazol. Curr Ther Res 1985; 38: 489–493.
   Web of Science ®Google Scholar
• Munoz JR, Villanueva C, Ramos JC, Menendez J, Bailon R, Vargas JA. Eficacia y tolerancia de 200 mg de fen-ticonazol vs 400 mg de miconazol en el tratamiento intravagi-nal de la vulvovaginitis micotica. Ginecologia y Obstetricia de Mexico 2002; 70: 59–65.
   PubMedGoogle Scholar
• Novelli A, Periti E, Massi GB, Masi R, Mazzei T, Periti P. Systemic absorption of 3H-fenticonazole after vaginal administration of 1 gram in patients. J Chemother 1991; 3 (1): 23–27.
   PubMed Web of Science ®Google Scholar
• Bukovski I, Schneider D, Arieli S, Caspi E. Fenticonazole in the treatment of vaginal trichomoniasis and vaginal mixed infections. Adv Ther 1991; 8 (4): 166–171.
   Web of Science ®Google Scholar
• Manth SM, Rindt W, Schnitker J, Weigerding A. Fenticonazole in the treatment of vaginal trichomonas infec-tions. Curr Ther Res 1989; 45 (6): 1060–1066.
   Web of Science ®Google Scholar
• Gorlero F, Macchiavalo S, PeRegatta L et al. Evaluation of the efficacy and tolerability of two different dosages of fen-ticonazole vaginal ovules (600 mg and 1000 mg) in patients with vaginal tricomoniasis: a controlled, double blind, random-ized clinical trial versus placebo. Curr Ther Res 1994; 55: 510–518.
   Google Scholar
• Gorlero F, Bosco P, Barbieri M et al. Fenticonazole ovules in the treatment of vaginal trichomonas infections. A double blind randomized pilot clinical trial. Curr Ther Res 1992; 51: 367–376.
   Google Scholar
• Nugent RP, Krohn MA, Hillier SL. Reliability of diag-nosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol 1991; 29 (2): 297–301.
   PubMed Web of Science ®Google Scholar
• Faro S. Tricomoniasis. In: Kaufman RH, Faro S, editors. Enfermedades benignas de la vulva y la vagina (Benign diseases of the vulva and vagina). Madrid: Mosby/Doyma Libros, S.A., 1996: 338-35 2.
   Google Scholar
• Samuelson J. Why metronidazole is active against both bacteria and parasites. Antimicrob Agents Chemother 1999; 43 (7): 1533–1541.
   PubMed Web of Science ®Google Scholar
• Forna F, Gulmezoglu AM. Interventions for treating tri-chomoniasis in women. Cochrane Database Syst Rev 2000; (3): CD000218.
   Google Scholar
• Josephson S, Thomason J, Sturino K, Zabransky R, Williams J. Gardnerella vaginalis in the urinary tract: inci-dence and significance in a hospital population. Obstet Gynecol 1988; 71 (2): 245-250.
   Google Scholar
• Murta EF, Souza MA, Araujo JE, Adad SJ. Incidence of Gardnerella vaginalis, Can dida sp and human papilloma virus in cytological smears. Sao Paulo Med J 2000; 118 (4): 105–108.
   PubMedGoogle Scholar
• Larsson PG. Treatment of bacterial vaginosis. Int J STD AIDS 1992; 3 (4): 239–247.
   PubMed Web of Science ®Google Scholar